Literature DB >> 30852434

A comparison of the reliability and validity of SF-6D, EQ-5D and HUI3 utility measures in patients with schizophrenia and patients with depression in Singapore.

Edimansyah Abdin1, Siow Ann Chong2, Esmond Seow2, Chao Xu Peh2, Jit Hui Tan2, Jianlin Liu2, Sophia Foo Si Hui2, Boon Yiang Chua2, Kang Sim2, Swapna Verma3, Janhavi Ajit Vaingankar2, Mythily Subramaniam2.   

Abstract

There is limited evidence of a direct comparison of the psychometric performance of generic preference-based measures in patients with mental illness in an Asian patient population. The current study aimed to compare the test-retest reliability, convergent and known-group validity and magnitude of change in scores of the EuroQol Five-Dimension, Health Utility Index Mark 3 (HUI3) and Short-Form Six-Dimension (SF-6D) measures in patients with depression and patients with schizophrenia spectrum disorder. 500 patients were recruited from a tertiary psychiatric institution in Singapore. The Schizophrenia Quality of Life Scale (SQLS), 8-item Patient Health Questionnaire, Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q), and Positive and Negative Syndrome Scale were also included. In the schizophrenia sample, the SF-6D was found to have higher test-retest validity, convergent validity with SQLS domain scores, known-group validity and magnitude of change in scores over 6-month follow up than other measures. In the depression sample, the HUI3 was found to have higher test-retest reliability, convergent validity with Q-LES-Q, known group validity and magnitude of change in scores than other measures. Results suggest that the SF-6D and HUI3 to be more suitable as a utility measure for patients with schizophrenia and depression in an Asian patient population.
Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 30852434     DOI: 10.1016/j.psychres.2019.02.077

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  7 in total

1.  Mapping the Shah-modified Barthel Index to the Health Utility Index Mark III by the Mean Rank Method.

Authors:  Yin Bun Cheung; Hui Xing Tan; Nan Luo; Hwee Lin Wee; Gerald C H Koh
Journal:  Qual Life Res       Date:  2019-07-27       Impact factor: 4.147

2.  Early age of onset of mood, anxiety and alcohol use disorders is associated with sociodemographic characteristics and health outcomes in adults: results from a cross-sectional national survey.

Authors:  Janhavi Ajit Vaingankar; Siow Ann Chong; Edimansyah Abdin; Saleha Shafie; Boon Yiang Chua; Shazana Shahwan; Swapna Verma; Mythily Subramaniam
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2021-03-31       Impact factor: 4.328

Review 3.  Time trade-off health state utility values for depression: a systematic review and meta-analysis.

Authors:  Péter György Balázs; Dalma Erdősi; Antal Zemplényi; Valentin Brodszky
Journal:  Qual Life Res       Date:  2022-09-30       Impact factor: 3.440

4.  Measuring intangible cost-of-morbidity due to substance dependence: implications of using alternative preference-based instruments.

Authors:  Bruno Casal; Eva Rodríguez-Míguez; Berta Rivera
Journal:  Eur J Health Econ       Date:  2020-05-17

Review 5.  Measurement Properties of Commonly Used Generic Preference-Based Measures in East and South-East Asia: A Systematic Review.

Authors:  Xinyu Qian; Rachel Lee-Yin Tan; Ling-Hsiang Chuang; Nan Luo
Journal:  Pharmacoeconomics       Date:  2020-02       Impact factor: 4.981

6.  The remarkably frequent use of EQ-5D in non-economic research.

Authors:  Aimin Wang; Kim Rand; Zhihao Yang; Richard Brooks; Jan Busschbach
Journal:  Eur J Health Econ       Date:  2021-11-30

7.  Comparison of the measurement properties of SF-6Dv2 and EQ-5D-5L in a Chinese population health survey.

Authors:  Shitong Xie; Dingyao Wang; Jing Wu; Chunyu Liu; Wenchen Jiang
Journal:  Health Qual Life Outcomes       Date:  2022-06-16       Impact factor: 3.077

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.